Biographical Sketch
Leonard H. Calabrese, DO, heads Cleveland Clinic's Section of Clinical Immunology and manages its Clinical Immunology Clinic. He specializes in diseases of the immune system -- in particular, immunodeficiency diseases, such as human immunodeficiency virus (HIV) and hepatitis C infections, which are the subject of both clinical care and investigation. Dr. Calabrese is also Co-director of the Center for Vasculitis Care and Research and has a particular interest in vascular inflammatory disease of the central nervous system.
A graduate of the Kansas City University of Medicine and Biosciences , Dr. Calabrese performed his internal medicine training at Cleveland Clinic in Ohio, followed by a fellowship in rheumatic and immunologic disease. He has been a staff member in Cleveland Clinic's Department of Rheumatic and Immunologic Diseases since 1980.
Recipient of numerous awards and honors, Dr. Calabrese has received the Phillips Medal of Public Service from Ohio University's College of Osteopathic Medicine and the Bruce Hubbard Stewart Award for humanitarianism. He holds the R.J. Fasenmeyer Chair of Clinical Immunology and is the director of the RJ Fasenmyer Center for Clinical Immunology. When he was awarded the Theodore F. Classen, DO Chair in Osteopathic Research and Education in 2008 he became the first dual-chair holder in Cleveland Clinic history.
Dr. Calabrese is a member of many professional societies, including the American Association of Immunology, Clinical Immunology Society and the International AIDS Society and the American Osler Society. He is a fellow of the American College of Rheumatology, American College of Physicians and the American College of Sports Medicine.
Dr. Calabrese has lectured nationally and internationally on the subjects of HIV, immunology and rheumatology and is the author of more than 300 published peer-reviewed articles, book chapters and reviews.
Specialty Interests
adult immunodeficiency states, CNS vasculitis, Hepatitis C, HIV & AIDS, retroperitoneal fibrosis, Vasculitis, HIV/AIDS
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/3/2008, Dr.
Calabrese has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Calabrese receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Abbott
Acumentis
Amgen/Wyeth
Centocor, Inc.
Genentech, Inc.
Roche Pharmaceuticals
Biogen Idec
Elan
